Skip to main content

Table 1 Complete Continence: Treatment Success Definition by Intervention

From: Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence

Study

Study Design

Sample Size

Study Population

Comparator

Success Evaluated (months)

Success %

Botulinum toxin type A

Kennelly, Top Spinal Cord Inj Rehabil, 2003 [26]

Open Label

10

NOAB

None

6

80

Reitz, Eur Urol, 2004 [27]

Open Label

200

NOAB

None

4

73

Giannantoni, J Urol, 2004 [28]

RCT

25

NOAB

Intravesically Resiniferation

18

73

Giannantoni, Minerva Urol Nephrol, 2004 [29]

RCT

12

NOAB

Intravesically Resiniferation

12

75.0

Klaphajone, Arch Phys Med Rehabil, 2005 [30]

Open Label

10

NOAB

None

1.5

70

Schurch, J Urol, 2005 [13]

RCT

38

NOAB

Placebo

6

63

Kessler, Neurourol Urodynam, 2005* [31]

Open Label

11, 11

NOAB, IOAB

None

3, 3

72, 91

Popat, J Urol, 2005* [32]

Open Label

31, 44

NOAB, IOAB

None

4, 4

55.2, 57

Werner, Am J Obstet Gynecol, 2005 [33]

Open Label

26

IOAB

None

9

65

Kuo, J Urol, 2006* [34]

Single Blind

35, 40

NOAB, IOAB

None

3, 3

94, 73

Giannantoni, J Urol, 2006 [35]

Open Label

23

NOAB

None

3

78

Karsenty, Urol, 2006 [36]

Open Label

17

NOAB

None

5

100

Sahai, J Urol, 2007 [37]

RCT

16

IOAB

Placebo

3

50

Mascarenhas, Neurourol. Urodynam, 2008 [38]

Open label

21

NOAB

None

2

42.8

Sacral neuromodulation

Bosch, J Urol, 2000 [39]

Open Label

6

NOAB

None

47

80

Chartier-Kastler, J Urol, 2000 [40]

Open Label

9

NOAB

None

43.6

67

Weil, Eur Urol, 2000 [41]

RCT

21

IOAB

Current Management

6

56

Spinelli, J Urol, 2001 [42]

Open Label

196

NOAB

None

18

71

Augmentation cystoplasty

Chartier-Kaslter, Spinal Cord, 2000 [43]

Open Label

17

NOAB

None

75.6

70.5

Ivil, Int Urol Nephrol, 2002 [44]

Open Label

17

IOAB

None

11

83

Khastgir, Eur Urol, 2003 [21]

Open Label

32

NOAB

None

72

100

Quek, J Urol, 2003 [45]

Open Label

26

NOAB

None

96

69

Stoffel, Neurourol Urodynam, 2006 [46]

Open Label

12

NOAB

None

20

88

  1. * Denotes a study with both neurogenic OAB (NOAB) and idiopathic OAB (IOAB) populations.
  2. Note: Studies may be listed in more than one category of treatment success if multiple definitions of treatment success were reported.